ZYBERNO
Stock Report
Updated Aug 27, 2026

Black Hawk Acquisition Corporation (BKHAU)

Healthcare • NASDAQ

$12.02

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
0.0/100
POOR BUSINESS
Black Hawk Acquisition Corporation (BKHAU) scores 0/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-2.1%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

Black Hawk Acquisition Corporation (BKHAU) stock report — Zyberno Score 0/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:12.02
Market Cap:$49.93M

Valuation Multiples (1)

Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$50.07M

Price Action & Momentum (3)

Momentum Percentile:58 / 100
% of 52-Week High:91.8%
B. Profitability Assessment

Margin Analysis (1)

Ebitda Margin:0.0%

Yield Metrics (2)

Earnings Yield:-$999.00
Dividend Yield:102.2%
C. Log-Linear Regression Growth Trends

Earnings Growth (Linear) (1)

Net Income Growth Rate (Linear):-50.0%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.02x
Quick Ratio:0.02x
Cash Ratio:0.00x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-0.79x
Times Interest Earned:-0.79

Capital Structure (4)

Working Capital:-2,688,676.00
Cash And Cash Equivalents:11,583.00
Long Term Debt:$0.00
Net Debt:$142.37K
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$0.00
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$722.55K

Bottom Line Performance (3)

Net income TTM: $1.56M
Linear Growth: -50.0%
📊 Click to view full BKHAU Net Income analysis & methodology →
Income Before Tax:$0.00
Ebitda Ttm:-722,547.00

Operating Expenses (5)

Operating Expenses:0.00
R And D Expense:0.00
Sga Expense:602,547.00
Income Tax Expense:$0.00
Interest Expense:1,161,064.00

Expense Ratios (1)

Ebitda Margin:0.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$25.38M
Current Assets:$63.13K
Ppe Net:0.00
Goodwill:0.00
Intangible Assets:$5.00M

Liability Structure (4)

Total Liabilities:30,479,922.00
Current Liabilities:2,751,806.00
Long Term Debt:$0.00
Short Term Debt:$153.95K

Equity & Capital (3)

Equity:-$5.10M
Retained Earnings:-$5.11M
Common Stock:203.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:0.00
Accounts Payable:153,952.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

-$596.51K$0.00

Investment Activities (1)

Investing Cash Flow:-$600.00K

Financing Activities (3)

Financing Cash Flow:$848.39K
Dividends Paid Ttm:51,010,745.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:690,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (1)

Earnings Per Share Ttm:$0.38

Revenue & Cash Per Share (1)

Operating Cash Flow Per Share:-$0.16

Book Value & Capital (2)

Book Value Per Share:-$1.23
Cash Per Share:0.00

Dividend Policy (1)

Dividend Payout Ratio:3,273.51x
B. Operational Efficiency

Asset Utilization (1)

Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:-999.00
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:20.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Net Income Growth Rate (Linear):-50.0%
C. Company Profile & Context

Corporate Information (6)

Symbol:BKHAU
Company Name:Black Hawk Acquisition Corporation
Sector:Healthcare
Industry:Biological Products, (No Diagnostic Substances)
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:medium
Volume Category:N/A

Share Structure (3)

Shares Outstanding:4.15M
Shares Outstanding Basic:0
Shares Outstanding Diluted:0

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-27 01:44:26 UTC
Data Timestamp:2026-08-27T01:44:26.395593
Scroll to Top